Skip to content

PPBT

Purple Biotech Ltd.

NASDAQ · Healthcare · Biotechnology · IL

$1.08
−5.26%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 13, 2026
EPS estimate
-$2.88
Revenue estimate
—

Latest reported

Last report date
Aug 7, 2026
EPS actual
$1.07
EPS estimate
-$0.98
Revenue actual
—
Revenue estimate
—

Track record

Trailing twelve quarters

EPS beats (12Q)
3
EPS misses (12Q)
7
EPS in line (12Q)
1
Avg surprise (4Q)
-47.1%
Revenue beats (12Q)
—
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 7, 2026-$0.98$1.07Beat 209.18%—
May 15, 2026-$3.80-$0.09Beat 97.63%—
Mar 13, 2026-$3.40-$20Miss -483.82%—
Nov 14, 2025-$0.26-$0.29Miss -11.54%—
Aug 6, 2025-$0.21-$0.40Miss -90.48%—
May 21, 2025—-$0.17——
Mar 10, 2025-$0.22-$0.26Miss -18.18%—
Nov 15, 2024-$1.20-$1.37Miss -14.17%—
Aug 16, 2024-$0.16-$1.60Miss -900.00%—
May 21, 2024-$3.00-$3.00In line—
Mar 5, 2024-$3.40-$6.40Miss -88.24%—
Nov 21, 2023-$4.40-$4.20Beat 4.55%—

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026